NASTECH PHARMACEUTICAL CO INC
10-Q/A, EX-27, 2000-11-15
PHARMACEUTICAL PREPARATIONS
Previous: NASTECH PHARMACEUTICAL CO INC, 10-Q/A, 2000-11-15
Next: DENTAL MEDICAL DIAGNOSTIC SYSTEMS INC, NT 10-Q, 2000-11-15



<TABLE> <S> <C>

<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                           7,896
<SECURITIES>                                         0
<RECEIVABLES>                                    1,034
<ALLOWANCES>                                         0
<INVENTORY>                                        204
<CURRENT-ASSETS>                                 9,334
<PP&E>                                           5,205
<DEPRECIATION>                                   1,531
<TOTAL-ASSETS>                                  13,218
<CURRENT-LIABILITIES>                            2,388
<BONDS>                                              0
                               41
                                          0
<COMMON>                                             0
<OTHER-SE>                                      10,789
<TOTAL-LIABILITY-AND-EQUITY>                    13,218
<SALES>                                            372
<TOTAL-REVENUES>                                 3,375
<CGS>                                              286
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                                11,511
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                (8,422)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (8,422)
<EPS-BASIC>                                     (1.33)
<EPS-DILUTED>                                   (1.33)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission